Role of tumor-associated macrophages in tumor progression and invasion

被引:727
作者
Mantovani, Alberto [1 ]
Schioppa, Tiziana
Porta, Chiara
Allavena, Paola
Sica, Antonio
机构
[1] Inst Clin Humanitas, I-20089 Milan, Italy
[2] Univ Milan, Inst Pathol, Ctr Eccellenza Innovaz Diagnost & Terapeut, I-20133 Milan, Italy
[3] Ist Ric Farmacol Mario Negri, I-20157 Milan, Italy
关键词
tumor-associated macrophages; tumor; inflammation; NF-kappa B; metastasis; hypoxia;
D O I
10.1007/s10555-006-9001-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Tumor-Associated Macrophages (TAM) represent the major inflammatory component of the stroma of many tumors, able to affect different aspects of the neoplastic tissue. Many observations indicate that TAM express several M2-associated protumoral functions, including promotion of angiogenesis, matrix remodelling and suppression of adaptive immunity. The protumoral role of TAM in cancer is further supported by clinical studies that found a correlation between the high macrophage content of tumors and poor patient prognosis and by evidence showing that long-term use of non-steroidal anti-inflammatory drugs reduces the risk of several cancers. Here, we discuss evidence supporting the view that TAM represent a unique and distinct M2-skewed myeloid population and a potential target of anti-cancer therapy.
引用
收藏
页码:315 / 322
页数:8
相关论文
共 85 条
  • [61] Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy
    Muller, AJ
    DuHadaway, JB
    Donover, PS
    Sutanto-Ward, E
    Prendergast, GC
    [J]. NATURE MEDICINE, 2005, 11 (03) : 312 - 319
  • [62] NF-κB as a therapeutic target in cancer
    Orlowski, RZ
    Baldwin, AS
    [J]. TRENDS IN MOLECULAR MEDICINE, 2002, 8 (08) : 385 - 389
  • [63] TUMOR-ASSOCIATED LEUKOCYTES - FRIENDS OR FOES IN BREAST-CARCINOMA
    OSULLIVAN, C
    LEWIS, CE
    [J]. JOURNAL OF PATHOLOGY, 1994, 172 (03) : 229 - 235
  • [64] Activators and target genes of Rel/NF-κB transcription factors
    Pahl, HL
    [J]. ONCOGENE, 1999, 18 (49) : 6853 - 6866
  • [65] A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer
    Paik, S
    Shak, S
    Tang, G
    Kim, C
    Baker, J
    Cronin, M
    Baehner, FL
    Walker, MG
    Watson, D
    Park, T
    Hiller, W
    Fisher, ER
    Wickerham, DL
    Bryant, J
    Wolmark, N
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (27) : 2817 - 2826
  • [66] Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene
    Pennacchietti, S
    Michieli, P
    Galluzzo, M
    Mazzone, M
    Giordano, S
    Comoglio, PM
    [J]. CANCER CELL, 2003, 3 (04) : 347 - 361
  • [67] NF-κB functions as a tumour promoter in inflammation-associated cancer
    Pikarsky, E
    Porat, RM
    Stein, I
    Abramovitch, R
    Amit, S
    Kasem, S
    Gutkovich-Pyest, E
    Urieli-Shoval, S
    Galun, E
    Ben-Neriah, Y
    [J]. NATURE, 2004, 431 (7007) : 461 - 466
  • [68] Tumour-educated macrophages promote tumour progression and metastasis
    Pollard, JW
    [J]. NATURE REVIEWS CANCER, 2004, 4 (01) : 71 - 78
  • [69] Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells -: In vivo neovascularization induced by stromal-derived factor-1α
    Salcedo, R
    Wasserman, K
    Young, HA
    Grimm, MC
    Howard, OMZ
    Anver, MR
    Kleinman, HK
    Murphy, WJ
    Oppenheim, JJ
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 1999, 154 (04) : 1125 - 1135
  • [70] Regulation of the chemokine receptor CXCR4 by hypoxia
    Schioppa, T
    Uranchimeg, B
    Saccani, A
    Biswas, SK
    Doni, A
    Rapisarda, A
    Bernasconi, S
    Saccani, S
    Nebuloni, M
    Vago, L
    Mantovani, A
    Melillo, G
    Sica, A
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (09) : 1391 - 1402